Expression of thymidylate synthase and dihydropyrimidine dehydrogenase in oral squamous cell carcinoma: possible markers as predictors of clinical outcome

References

• Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3: 330–8
   PubMed Web of Science ®Google Scholar
• Banwejee D, Mayer-Kuckuk P, Capiaux G, Budak-Alpdogan T, Gorlick R, Bertino JR. Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. Biochim Biophys Acta 2002; 1587: 164–73
   PubMedGoogle Scholar
• Omura K. Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines. Int J Clin Oncol 2003; 8: 132–8
   PubMedGoogle Scholar
• Allegra CJ, Paik S, Colangelo LH, Parr AL, Kirsch I, Kim G, et al. Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes’ B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study. J Clin Oncol 2003; 21: 241–50
   PubMed Web of Science ®Google Scholar
• Kawasaki G, Yoshitomi I, Yanamoto S, Mizuno A. Thymidylate synthase and dihydropyrimidine dehydrogenase expression in oral squamous cell carcinoma: an immunohistochemical and clinicopathologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94: 717–23
   PubMedGoogle Scholar
• Kornmann M, Schwabe W, Sander S, Kron M, Strater J, Polat S, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil. Clin Cancer Res 2003; 9: 4116–24
   PubMed Web of Science ®Google Scholar
• Johnston PG, Fisher ER, Rockette HE, Fisher B, Wolmark N, Drake JC, et al. The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clin Oncol 1994; 12: 2640–7
   PubMed Web of Science ®Google Scholar
• Johnston PG, Mick R, Recant W, Behan KA, Dolan ME, Ratain MJ, et al. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. J Natl Cancer Inst 1997; 89: 308–13
   PubMed Web of Science ®Google Scholar
• Shiga H, Heath EI, Rasmussen A, Trock B, Johnston PG, Forastiere AA, et al. Prognostic value of p53, glutathione S-transferase π, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 1999; 5: 4097–104
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Koike T, Nakatsuka A, Kurita H, Sagara J, Taniguchi S, et al. Dihydropyrimidine dehydrogenase expression predicts survival outcome and chemosensitivity to 5-fluorouracil in patients with oral squamous cell carcinoma. Oral Oncol 2005; 41: 38–47
   PubMed Web of Science ®Google Scholar
• Obata A, Eura M, Sasaki J, Saya H, Chikamatsu K, Tada M, et al. Clinical significance of p53 functional loss in squamous cell carcinoma of the oropharynx. Int J Cancer 2000; 89: 187–93
   PubMedGoogle Scholar
• Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, et al. Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986; 47: 381–9
   PubMed Web of Science ®Google Scholar
• Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650–4
   PubMed Web of Science ®Google Scholar
• Kato A, Miyazaki M, Ambiru S, Yoshiotmi H, Ito H, Nakagawa K, et al. Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection. J Surg Oncol 2001; 78: 110–15
   PubMed Web of Science ®Google Scholar
• Raspadori D, Damiani D, Michieli M, Stocchi R, Gentili S, Gozzetti A, et al. CD56 and PGP expression in acute myeloid leukemia: impact on clinical outcome. Haematologica 2002; 87: 1135–140
   PubMed Web of Science ®Google Scholar
• Sakakura K, Chikamatsu K, Sakurai T, Takahashi K, Murata T, Oriuchi N, et al. Infiltration of dendritic cells and NK cells into the sentinel lymph node in oral cavity cancer. Oral Oncol 2005; 41: 89–96
   PubMed Web of Science ®Google Scholar
• Ichikawa W, Takahashi T, Suto K, Nihei Z, Shirota Y, Shimizu M, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Int J Cancer 2004; 112: 967–73
   PubMedGoogle Scholar
• Uematsu T, Hasegawa T, Hiraoka BY, Komatsu F, Matsuura T, Yamada A, et al. Multidrug resistance gene 1 expression in salivary gland adenocarcinomas and oral squamous-cell carcinomas. Int J Cancer 2001; 92: 187–94
   PubMedGoogle Scholar
• Danenberg PV. Thymidylate synthase – a target enzyme in cancer chemotherapy. Biochem Biophys Acta 1977; 473: 73–92
   PubMed Web of Science ®Google Scholar
• Lizard-Nacol S, Genne P, Coudert B, Riedinger JM, Arnal M, Sancy C, et al. MDR1 and thymidylate synthase (TS) gene expressions in advanced breast cancer: relationships to drug exposure, p53 mutations, and clinical outcome of the patients. Anticancer Res 1999; 19: 3575–81
   PubMed Web of Science ®Google Scholar
• Miyoshi T, Kondo K, Fujino H, Takahashi Y, Sawada N, Sakiyama S, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer: relationship between mRNA expression and activity. Anticancer Res 2005; 25: 923–30
   PubMedGoogle Scholar
• Fujiwaki R, Iida K, Nakayama K, Kanasaki H, Ozaki T, Hata K, et al. Dihydropyrimidine dehydrogenase in normal and malignant endometrium: relationship with cell proliferation and thymidine phosphorylase. Virchows Arch 2003; 443: 672–7
   PubMedGoogle Scholar
• Harris CC. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 1996; 88: 1442–55
   PubMed Web of Science ®Google Scholar
• Etienne MC, Chazal M, Laurent-Puig P, Magne M, Rosty C, Formento JL, et al. Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol 2002; 20: 2832–43
   PubMed Web of Science ®Google Scholar
• Jain V, Das SN, Luthra K, Shukla NK, Ralhan R. Differential expression of multidrug resistance gene product, P-glycoprotein, in normal, dysplastic and malignant oral mucosa in India. Int J Cancer 1997; 74: 128–33
   PubMed Web of Science ®Google Scholar
• Cho YS, Kim MJ. Expression of multidrug resistance-related genes in oral squamous cell carcinomas. Oral Oncol 2001; 37: 652–9
   PubMedGoogle Scholar